IART vs KIDS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IART Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Integra LifeSciences Holdings (IART) driven by superior Valuation, Growth & Margin, Options & Structure while KIDS counters with relative strength in Momentum & Technical. Fundamentally, IART trades at 5.7x Forward P/E with 9.9% operating margin (+2.3% YoY revenue) versus KIDS at N/M Forward P/E and -8.2% operating margin (+18.6% YoY). In options structure, IART sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against KIDS sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IART | KIDS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $850.2M | Larger Scale | IART |
| Trailing P/E Ratio Valuation | 81.5x | N/M | Lower Multiple | IART |
| Forward P/E Ratio Valuation | 5.7x | N/M | Lower Multiple | IART |
| Revenue Growth (YoY) Growth | +2.3% | +18.6% | Higher Growth | KIDS |
| Operating Margin (TTM) Profitability | 9.9% | -8.2% | Higher Margin | IART |
| Net Profit Margin Profitability | 0.8% | -12.8% | Higher Margin | IART |
| Return on Equity (ROE) Capital Efficiency | 1.2% | -9.8% | Higher ROE | IART |
| 52-Week Range Position Momentum | 41% ($9โ$20) | 90% ($14โ$35) | Stronger Trend | KIDS |
| Beta / 30D Volatility Risk Regime | 1.57ฮฒ ยท 61% Vol | 0.81ฮฒ ยท 108% Vol | Lower Realized Risk | IART |
| Unified Institutional Score Composite Signal | 48.5 / 100 (HOLD) | 45.1 / 100 (HOLD) | Higher Composite | IART |